This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
Tim Wilsdon and Antun Sablek present their new study analyzing the expected impact of the GPL on the biotechnology innovation ecosystem. The webinar will discuss the consequences of this landmark legislation for the future of innovation in healthcare in Europe, EU patients and economies within a global race towards health security and competitiveness.
For more information on this event, click here.
Navigating payer challenges for rare disease treatments requires innovative approaches to evidence generation and pricing strategies. Our Life Sciences...
Access to medicine and healthcare services poses persistent challenges, especially in low-income regions with high out-of-pocket expenses. Pharmaceutical...
Kirsten Axelsen moderates the PhRMA-sponsored panel session titled “Progress or Regress…How does CMS’ Maximum Fair Price Negotiation align with...
CRA is a proud sponsor of the MAPS organization. Ayushman Ghosh and Michelle Guo host the roundtable discussion titled “Strategic applications of Machine...
